Doctor profile · Federal record
Dr. Mark Jeranko, D.O.
Rheumatology Physician (CMS: Rheumatology) · Rheumatology Physician · Loveland, CO
- NPI 1114304573
- Accepts Medicare
- 11 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2500 Rocky Mountain Ave Ste 2200
Loveland, CO 805389004
(970) 652-2333
fax (970) 593-9731
Credentials & registration
- NPI registered
- May 2015 — 11 yrs on file
- Profile last updated
- April 10, 2026
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State licenses (2)
- Colorado #DR.0064290 · Michigan #5101021529
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1114304573. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
18,169
Distinct HCPCS
10
Medicare allowed
$277,130
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 13,360 | 14 | $6 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 2,125 | 20 | $43 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 1,380 | 24 | $33 | |
J0897 |
Injection, denosumab, 1 mg | 720 | 12 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 118 | 88 | $127 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 81 | 59 | $136 | |
J7050 |
Infusion, normal saline solution, 250 cc | 74 | 50 | $1 | |
J3489 |
Injection, zoledronic acid, 1 mg | 70 | 14 | $10 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 68 | 40 | $29 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 63 | 48 | $66 |
In context: peer comparison
Among 1 peers in Loveland Rheumatology Physician, average services per provider: 1,297. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$1,450
Transactions
59
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen INC. | 21 | $582.72 | |
| Ucb, INC. | 11 | $258.69 | |
| AstraZeneca Pharmaceuticals Lp | 6 | $165.80 | |
| Lilly USA, LLC | 4 | $70.01 | |
| Abbvie INC. | 2 | $47.58 | |
| Pfizer INC. | 2 | $47.12 | |
| Ani Pharmaceuticals, INC. | 2 | $42.18 | |
| Janssen Biotech, INC. | 2 | $38.54 | |
| Radius Health, INC. | 2 | $37.27 | |
| Kiniksa Pharmaceuticals International, Plc | 2 | $34.39 | |
| Novartis Pharmaceuticals Corporation | 1 | $26.97 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $26.22 | |
| Celltrion USA INC. | 1 | $22.50 | |
| Scilex Pharmaceuticals INC. | 1 | $16.66 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $16.64 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
615
Patients
260
Total drug cost
$437,647
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 121 | 65 | $4,106 |
| Prednisone | Generic | 113 | 72 | $1,178 |
| Hydroxychloroquine Sulfate | Generic | 77 | 37 | $4,837 |
| Allopurinol | Generic | 51 | 20 | $1,251 |
| Alendronate Sodium | Generic | 39 | 12 | $325 |
| Folic Acid | Generic | 31 | 14 | $198 |
| Gabapentin | Generic | 29 | 14 | $798 |
| Enbrel Sureclick (Etanercept) | Brand | 26 | 0 | $196,809 |
| Sulindac | Generic | 23 | 12 | $806 |
| Meloxicam | Generic | 21 | 14 | $170 |
Frequently asked questions
What is Dr. Mark Jeranko's medical specialty?
Dr. Mark Jeranko practices Rheumatology Physician in Loveland, CO.
Where does Dr. Mark Jeranko practice?
Dr. Mark Jeranko practices at 2500 Rocky Mountain Ave Ste 2200, Loveland, CO 805389004. Office phone: 9706522333.
What is Dr. Mark Jeranko's NPI?
Dr. Mark Jeranko's National Provider Identifier (NPI) is 1114304573, issued by NPPES.
Does Dr. Mark Jeranko accept Medicare assignment?
Yes. Dr. Mark Jeranko accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Jeranko commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745). Source: CMS Medicare Physician & Other Practitioners file.